Home›Companies›Biotech & Pharma›Gaius

Gaius Therapeutics, Inc,

Cell therapies for people with autoimmune diseases.

Updated Nov 10, 2026·Latest SEC filing May 14, 2026·Suggest an edit

About Gaius

Gaius is a private company based in San Diego, California, incorporated in 2026 in Delaware. It has reported $60,000 raised in one offering on Form D since May 2026. Its chief executive is Jesse Solvason.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 7, 2026May 14, 2026$60,000of $250K target2$30,000Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Gaius's Form D filed May 14, 2026.

AK
Adam Klie
Executive officer
JS
Jesse Solvason
Chief Executive Officer and director
JA
Javid Aceil
Executive officer

Sources

  1. SECGaius Therapeutics, Inc, filing history